1-3 of 3
Ahuva Bar-Ilan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mod-5014, a Long-Acting FVIIa-CTP, Proposing a Novel Prophylactic Treatment Supporting Less Frequent Subcutaneous or Intravenous Injections with a Similar Mechanism of Action to rFVIIa: Proof-of-Concept in Hemophilic Animal Models

Lior Binder, MSc, Ahuva Bar-Ilan, PhD, Malka Hoffman, Gili Hart, PhD
Journal: Blood
Blood (2015) 126 (23): 4670.
https://doi.org/10.1182/blood.V126.23.4670.4670
Published: 2015
Journal Articles

Factor VIIa-CTP, a Novel Long-Acting Coagulation Factor, Displays a Prolonged Hemostatic Effect and Augmented Pharmacokinetics and pharmacodynamics Following IV and SC Administration in Hemophilic Animal Models

Gili Hart, PhD, Oren Hershkovitz, PhD, Ahuva Bar-Ilan, PhD, Uri Seligsohn, MD, Eyal Fima, PhD
Journal: Blood
Blood (2012) 120 (21): 1114.
https://doi.org/10.1182/blood.V120.21.1114.1114
Published: 2012
Journal Articles

The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46

Tal I. Arnon, Hagit Achdout, Niva Lieberman, Roi Gazit, Tsufit Gonen-Gross, Gil Katz, Ahuva Bar-Ilan, Noga Bloushtain, Marianna Lev, Aviva Joseph, Eli Kedar, Angel Porgador, Ofer Mandelboim
Journal: Blood
Blood (2004) 103 (2): 664–672.
https://doi.org/10.1182/blood-2003-05-1716
Published: 2004